Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma

NCT00538733 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: thalomid
DRUG: lenalidomide
DRUG: clarithromycin
DRUG: dexamethasone

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]